Filtros de búsqueda

Lista de obras de

A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Novel Drivers of Disease Progression in Primary Sclerosing Cholangitis

artículo científico publicado en 2020

A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH

artículo científico publicado en 2019

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

artículo científico publicado en 2016

A Proton Pump Inhibitor a Day Keeps the Iron Away.

artículo científico publicado en 2015

A Randomized Trial of Obeticholic Acid Monotherapy in Patients with Primary Biliary Cholangitis.

artículo científico publicado en 2017

A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.

artículo científico publicado en 2017

A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1 ⬇️

artículo científico publicado el 22 de febrero de 2013

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

artículo científico publicado en 2014

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

scientific article published on 09 March 2020

A research agenda for curing chronic hepatitis B virus infection.

artículo científico publicado en 2017

A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease

artículo científico publicado en 2005

ABT-450/ ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus

artículo científico

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

artículo científico publicado en 2014

ACG Clinical Guideline: Hereditary Hemochromatosis

artículo científico publicado en 2019

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

artículo científico publicado en 2015

ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy

artículo científico publicado en 2013

ACP Journal Club. Pioglitazone reduced liver injury and improved fasting glucose in nonalcoholic steatohepatitis without diabetes

artículo científico publicado en 2009

ACP Journal Club. Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis

artículo científico publicado en 2010

ACP Journal Club. The Glasgow-Blatchford Bleeding Score identified patients with upper GI bleeding who could be managed as outpatients

artículo científico publicado en 2009

Abnormal liver test results on routine screening. How to evaluate, when to refer for a biopsy

artículo científico publicado en 2004

Acidophil bodies in nonalcoholic steatohepatitis

artículo científico publicado en 2016

AddingN-acetylcysteine to prednisolone reduced early mortality in severe alcoholic hepatitis

artículo científico publicado el 15 de mayo de 2012

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

artículo científico publicado en 2004

Adiponectin--tipping the scales from NAFLD to NASH?

artículo científico publicado en 2005

Advances in the diagnosis and treatment of nonalcoholic steatohepatitis

artículo científico publicado en 2014

Airway obstruction complicating esophageal stent placement in two post-pneumonectomy patients

artículo científico publicado en 2004

Alcohol intake and iron overload: another role for hepcidin?

scientific article published on 01 February 2007

Alcohol’s Effect on Other Chronic Liver Diseases ⬇️

artículo científico publicado el 1 de noviembre de 2012

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

artículo científico publicado en 2015

Allogeneic Transplantation, Fas Signaling, and Dysregulation of Hepcidin ⬇️

artículo científico publicado el 22 de mayo de 2013

Alpha1-Antitrypsin Deficiency: A Cause of Chronic Liver Disease

artículo científico publicado en 2020

An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis

artículo científico publicado en 2017

An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis

artículo científico publicado en 2009

Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection

artículo científico publicado en 2015

Anemia management in the era of triple combination therapy for chronic HCV ⬇️

artículo científico publicado el 1 de septiembre de 2012

Approach to a Patient with Elevated Serum Alkaline Phosphatase ⬇️

artículo científico publicado el 6 de abril de 2012

Association between metabolic syndrome and liver histology among NAFLD patients without diabetes

artículo científico publicado en 2016

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2019

Association of hepatic iron overload with invasive fungal infection in liver transplant recipients

artículo científico publicado en 2006

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

artículo científico publicado en 2010

Biting the iron bullet: endoplasmic reticulum stress adds the pain of hepcidin to chronic liver disease

artículo científico publicado en 2010

Built to last? Durability of lamivudine-induced seroconversion in patients with chronic hepatitis B

scientific article published on 01 June 2004

CT-guided transfemoral portocaval shunt creation

scientific article published on 01 March 2001

CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease

artículo científico publicado en 2003

Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure

artículo científico publicado en 2004

Cellular microRNA and the tumorigenesis of hepatocellular carcinoma ⬇️

artículo científico publicado el 1 de marzo de 2012

Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

scientific article published on 13 January 2020

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort

scientific article published on 01 October 2019

Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases

artículo científico publicado en 2013

Chemoprevention of hepatocellular carcinoma in chronic hepatitis B with lamivudine?

artículo científico publicado en 2005

Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals

artículo científico publicado en 2018

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

artículo científico publicado en 2011

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

artículo científico publicado en 2010

Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis due to NASH

scientific article published on 10 November 2020

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

artículo científico publicado en 2016

Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity

artículo científico publicado en 2014

Complications after ERCP in patients with primary sclerosing cholangitis

artículo científico publicado en 2007

Controversies in the Diagnosis and Management of NAFLD and NASH.

artículo científico publicado en 2014

Correction: ACG Clinical Guideline: Hereditary Hemochromatosis

artículo científico publicado en 2019

Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients

artículo científico publicado en 2007

Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2007

Curcumin and Turmeric Modulate the Tumor-Promoting Effects of Iron In Vitro

artículo científico publicado en 2017

Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells

artículo científico publicado en 2008

Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).

artículo científico publicado en 2017

Current and future therapy in haemochromatosis and Wilson's disease

artículo científico publicado en 2003

Current and potential treatments for primary biliary cholangitis

artículo científico publicado en 2019

Current perspectives into the evaluation and management of hepatitis B: a review

scientific article published on 01 August 2019

Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans

artículo científico publicado en 2014

Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States.

artículo científico publicado en 2015

Dendritic cells in NASH: Friend or foe? ⬇️

artículo científico publicado el 1 de mayo de 2013

Developing clinical research in a clinical hepatology practice

artículo científico publicado en 2017

Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO.

artículo científico publicado en 2017

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.

artículo científico

Diagnosis and Management of Primary Biliary Cholangitis

scientific article published on 01 January 2019

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases

artículo científico publicado en 2011

Diagnosis and treatment of hereditary hemochromatosis: an update

artículo científico publicado en 2013

Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis.

artículo científico publicado en 2017

Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice ⬇️

artículo científico publicado el 20 de junio de 2011

Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.

artículo científico publicado en 2007

Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis

artículo científico publicado en 2017

Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes

scientific article published on July 2009

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network

artículo científico publicado en 2016

Disruption of Iron Regulation after Radiation and Donor Cell Infusion

scientific article published on 06 April 2016

Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection

artículo científico publicado en 2015

Durability of serologic response after lamivudine treatment of chronic hepatitis B.

artículo científico publicado en 2003

Effect of alcohol on viral hepatitis and other forms of liver dysfunction

artículo científico publicado en 2005

Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study

artículo científico publicado en 2007

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

artículo científico publicado en 2002

Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis

scientific article published on 04 January 2019

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial ⬇️

artículo científico publicado el 4 de agosto de 2013

Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?

artículo científico publicado en 2006

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients With HCV Genotype 5/6: An Integrated Analysis of Phase 2/3 Studies

artículo científico publicado en 2020

Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection

scientific article published on 12 March 2019

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients with HCV Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

artículo científico publicado en 2017

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial

artículo científico publicado en 2016

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

artículo científico publicado en 2014

Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection

artículo científico publicado en 2016

Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists

artículo científico publicado en 2020

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis

artículo científico publicado en 2020

Endpoints and clinical trial design for nonalcoholic steatohepatitis

artículo científico publicado en 2011

Epidemiologic features of a large hepatitis C cohort evaluated in a major health system in the western United States

artículo científico publicado en 2019

Epidemiology of hepatitis B--clinical implications.

artículo científico publicado en 2006

Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study

artículo científico publicado en 2016

Expansion of criteria for liver transplantation in HCC: a slippery slope?

artículo científico publicado en 2002

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C ⬇️

artículo científico publicado el 3 de enero de 2013

Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis

scientific article published on 15 September 2018

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

scientific article published on 13 August 2019

Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT.

artículo científico publicado en 2008

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

artículo científico publicado en 2015

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

scientific article published on 17 October 2019

Financial Compensation For Hepatologists in Different Practice Settings

scientific article published on 12 March 2019

Fulminant hepatic failure secondary to neoplastic infiltration of the liver

artículo científico publicado en 2005

Gastric varices: an updated review of management

artículo científico publicado en 2011

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

artículo científico publicado en 2016

Global epidemiology of hepatitis B virus

artículo científico publicado en 2004

Glyceronephosphate O-acyltransferase as a hemochromatosis modifier gene: Another iron in the fire?

artículo científico publicado en 2015

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

artículo científico publicado en 2020

Gut instinct: Rifaximin for the prevention of hepatic encephalopathy ⬇️

artículo científico publicado el 1 de agosto de 2010

HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis

artículo científico publicado en 2007

HFE-associated hereditary hemochromatosis

scientific article published on 01 May 2009

Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis

scientific article published on 01 November 2019

Hematologic side effects of PEG interferon and ribavirin. Management with growth factors

artículo científico publicado en 2005

Hematologic side effects of interferon and ribavirin therapy

artículo científico publicado en 2005

Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

artículo científico publicado en 2011

Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2018

Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis

artículo científico

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease ⬇️

artículo científico publicado el 14 de marzo de 2013

Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

artículo científico publicado en 2015

Hepatitis B and liver transplantation

artículo científico publicado en 2005

Hepatitis C, iron status, and disease severity: relationship with HFE mutations

artículo científico publicado en 2003

Hepcidin in HFE-associated hemochromatosis: another piece of the "iron" puzzle

artículo científico publicado en 2004

Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice

artículo científico publicado en 2010

Hereditary hemochromatosis: a review of the genetics, mechanism, diagnosis, and treatment of iron overload

artículo científico publicado en 2006

Hereditary hemochromatosis: genetics, pathogenesis, and clinical management.

artículo científico publicado en 2005

Hereditary hemochromatosis: time for targeted screening

artículo científico publicado en 2008

High rates of viral suppression after long-term entecavir treatment of Asian patients with hepatitis B e antigen-positive chronic hepatitis B.

artículo científico publicado en 2012

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

artículo científico publicado en 2009

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

artículo científico publicado en 2011

Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels

artículo científico publicado en 2019

Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels

artículo científico publicado en 2010

How to approach an elevated ferritin level?

scientific article published on 01 June 2002

Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate

artículo científico publicado en 2004

Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed

artículo científico publicado en 2019

IkappaB kinase epsilon: a potential therapeutic target for obesity (and nonalcoholic fatty liver disease)?

artículo científico publicado en 2010

Improvement in liver histology among Asian patients with chronic hepatitis B after long‐term treatment with entecavir ⬇️

artículo científico publicado el 1 de abril de 2013

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

artículo científico publicado en 2015

In search of vulcan: Where are all the iron men (and women)?

artículo científico publicado en 2002

Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy

artículo científico publicado en 2006

Initiation of methamphetamine abuse during interferon treatment

scientific article published on 01 September 2007

Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma ⬇️

artículo científico publicado el 1 de mayo de 2011

Investigational drugs in early phase development for biliary cholangitis

scientific article published on 30 November 2020

Iron Overload (with Attention to Genetic Testing and Diagnosis/Management of HFE Wild Type Patients)

artículo científico publicado en 2006

Iron Overload Causes Oxidative Stress and Impaired Insulin Signaling in AML-12 Hepatocytes ⬇️

artículo científico publicado el 5 de abril de 2013

Iron Overload in Patients With Chronic Liver Disease

artículo científico publicado en 2016

Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis

artículo científico publicado en 2019

Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?

scientific article published on 01 August 2003

Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin

artículo científico publicado en 2013

Iron in hepatitis C: villain or innocent bystander?

artículo científico publicado en 2002

Iron metabolism and diagnosis of iron overload disorders ⬇️

artículo científico publicado el 1 de enero de 2010

Iron metabolism in Nonalcoholic Fatty Liver Disease

artículo científico

Iron overload related to excessive vitamin C intake

artículo científico publicado en 2003

Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice

artículo científico publicado en 2015

Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen?

artículo científico publicado en 2003

Iron, hemochromatosis, and hepatocellular carcinoma

artículo científico publicado en 2004

Is Silymarin Hepatoprotective in Alcoholic Liver Disease? ⬇️

artículo científico publicado el 1 de octubre de 2003

Is central obesity associated with cirrhosis-related death or hospitalization? A population-based, cohort study

article

Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study

artículo científico publicado en 2003

Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids

artículo científico publicado en 2017

It TAK(es) 1 to prevent steatohepatitis and tumorigenesis.

artículo científico publicado en 2014

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study

artículo científico publicado en 2014

Liver involvement in patients with solid tumors of nonhepatic origin

artículo científico publicado en 2002

Liver transplantation for metabolic liver diseases

scientific article published on 01 May 2007

Liver transplantation: an "in vivo" model for the pathophysiology of hemochromatosis?

artículo científico publicado en 2004

Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients with Nonalcoholic Steatohepatitis: Analysis of Data from a Phase 2 Trial of Selonsertib

article

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations ⬇️

artículo científico publicado el 20 de septiembre de 2012

Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome

artículo científico publicado en 2017

Management of biliary complications following orthotopic liver transplantation

artículo científico publicado en 2007

Management of chronic hepatitis B infection

artículo científico publicado en 2015

Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

artículo científico publicado en 2020

Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis

scientific article published on 08 March 2019

Metal storage disorders: Wilson disease and hemochromatosis

artículo científico

Metals and the liver ⬇️

artículo científico publicado el 1 de mayo de 2012

Method for microRNA isolation from clinical serum samples ⬇️

artículo científico publicado el 11 de septiembre de 2012

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis

artículo científico publicado en 2005

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis

scientific article published on 05 December 2019

MicroRNAs in Common Human Diseases ⬇️

artículo científico publicado el 29 de septiembre de 2012

MicroRNAs in Liver Disease: Bench to Bedside

artículo científico publicado en 2013

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.

artículo científico publicado en 2017

Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?

artículo científico publicado en 2016

Motion - prophylactic banding of esophageal varices is useful: arguments against the motion

artículo científico publicado en 2002

Multicenter validation of association between decline in MRI-PDFF and histologic response in nonalcoholic steatohepatitis

artículo científico publicado en 2020

Nadolol and isosorbide prevented recurrent variceal bleeding better than did endoscopic ligation in cirrhosis

artículo científico publicado en 2002

Natural history of nonalcoholic steatohepatitis

artículo científico publicado en 2006

New developments in the treatment of primary biliary cholangitis - role of obeticholic acid

artículo científico publicado en 2017

No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients

artículo científico publicado en 2018

Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management

artículo científico publicado en 2005

Nonalcoholic steatohepatitis: a twenty-first century epidemic?

artículo científico publicado en 2006

Novel cytochrome P450-2D6 promoter sequence variations in hepatitis C positive and negative subjects ⬇️

artículo científico publicado el 1 de julio de 2011

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

scientific article published on 16 December 2019

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2017

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

scientific article published on 05 December 2019

Obeticholic acid for the treatment of nonalcoholic steatohepatitis

artículo científico publicado en 2020

Obeticholic acid in primary biliary cholangitis: where we stand

artículo científico publicado en 2019

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease.

artículo científico publicado en 2018

Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine

artículo científico publicado en 2015

On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir

artículo científico publicado en 2016

Optimal duration of therapy in HBV-related cirrhosis

artículo científico publicado en 2007

Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

artículo científico publicado en 2017

Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir

artículo científico publicado en 2017

Pediatric cholestatic liver disease: Successful transition of care

artículo científico publicado en 2019

Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease

artículo científico publicado en 2017

Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features ⬇️

artículo científico publicado el 1 de julio de 1995

Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.

artículo científico publicado en 2014

Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic

artículo científico publicado en 2009

Pilot Study of the Relationship Between Histologic Progression and Hepatic Iron Concentration in Chronic Hepatitis C ⬇️

artículo científico publicado el 1 de noviembre de 2003

Pioglitazone for patients with type 2 diabetes and nonalcoholic steatohepatitis

scientific article published on 01 March 2007

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

artículo científico publicado en 2008

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

artículo científico publicado en 2010

Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome

artículo científico publicado en 2002

Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir

artículo científico publicado en 2016

Practice patterns in NAFLD and NASH: real life differs from published guidelines

artículo científico publicado en 2016

Predicting outcome in primary biliary cirrhosis

artículo científico publicado en 2014

Prediction of Varices in Patients With Cirrhosis: A High-Stakes Numbers Game? ⬇️

artículo científico publicado el 1 de enero de 2002

Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies

artículo científico publicado en 2012

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery ⬇️

artículo científico publicado el 1 de noviembre de 2003

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

artículo científico publicado en 2016

Prevalence of autoimmune liver disease in Alaska Natives

artículo científico publicado en 2002

Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin ⬇️

artículo científico publicado el 16 de febrero de 2012

Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry

artículo científico publicado en 2007

Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management

scientific article published on 01 March 2020

Prognostic Factors in Acute Pancreatitis ⬇️

artículo científico publicado el 1 de febrero de 2002

Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines ⬇️

artículo científico publicado el 16 de abril de 2012

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network

artículo científico publicado en 2009

Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy

artículo científico publicado en 2005

Racial differences in the relationship between hepatitis C infection and iron stores

artículo científico publicado en 2003

Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients

artículo científico publicado en 2007

Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis

artículo científico publicado en 2014

Relation between vitamin D status and nonalcoholic fatty liver disease in children ⬇️

artículo científico publicado en 2015

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up st

artículo científico publicado el 21 de agosto de 2012

Relationship between gene expression of duodenal iron transporters and iron stores in hemochromatosis subjects

artículo científico publicado en 2009

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

artículo científico publicado en 2010

Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis

artículo científico publicado en 2019

Relationship between transferrin-iron saturation, alcohol consumption, and the incidence of cirrhosis and liver cancer

artículo científico publicado en 2007

Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin

artículo científico publicado en 2005

Reply to HEP-20-0140 Letter to the Editors: Could Butyrate Be Incorporated With Farnesoid X Receptor Agonist Cilofexor to Enhance Primary Sclerosing Cholangitis Treatment?

artículo científico publicado en 2020

Reply: To PMID 21953442

artículo científico publicado en 2013

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop.

artículo científico publicado en 2017

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C ⬇️

artículo científico publicado el 4 de junio de 2013

Review: antibiotic prophylaxis reduces mortality and bacterial infection in cirrhosis and gastrointestinal bleeding

artículo científico publicado en 2002

Review: magnetic resonance cholangiopancreatography is accurate for diagnosing biliary disease.

artículo científico publicado en 2004

Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis

artículo científico publicado en 2018

Rheumatologic Disease and the Liver ⬇️

artículo científico publicado el 1 de febrero de 2011

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

artículo científico publicado en 2008

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection

artículo científico publicado en 2016

Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

artículo científico publicado en 2012

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

artículo científico publicado en 2015

Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older

artículo científico publicado en 2015

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

artículo científico publicado en 2015

Serum Ferritin Is An Independent Predictor of Histologic Severity and Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease ⬇️

artículo científico publicado el 6 de diciembre de 2011

Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis

artículo científico publicado el 15 de abril de 2003

Serum ferritin as a biomarker for NAFLD: ready for prime time?

scientific article published on 09 February 2019

Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women

artículo científico publicado en 2013

Serum hepcidin levels are associated with obesity but not liver disease.

artículo científico publicado en 2013

Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C.

artículo científico publicado en 2008

Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study

artículo científico publicado en 2008

Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

artículo científico publicado en 2020

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial

artículo científico publicado en 2012

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

artículo científico publicado en 2013

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

artículo científico publicado en 2013

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

artículo científico publicado en 2017

Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation

scientific article published on 14 November 2018

Sorafenib: A glimmer of hope for unresectable hepatocellular carcinoma?

artículo científico publicado en 2009

Spontaneous Bacterial Peritonitis.

artículo científico publicado en 2015

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

artículo científico publicado en 2015

Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry

artículo científico publicado en 2005

Synopsis for the Yale Workshop on Hepatocellular Carcinoma

artículo científico publicado en 2002

Temporary support for acute liver failure

artículo científico publicado en 2002

The Effects of Alcohol on Other Chronic Liver Diseases

artículo científico publicado en 2016

The Management of Chronic Hepatitis B in Asian Americans ⬇️

artículo científico publicado el 21 de septiembre de 2011

The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis

artículo científico publicado en 2015

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

artículo científico publicado en 2019

The North American Study for the Treatment of Refractory Ascites

artículo científico publicado en 2003

The Prevalence and Presumed Etiology of Elevated Aminotransferase Levels in a Pacific Northwest Tribal Community

artículo científico publicado en 2015

The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma

artículo científico publicado en 2016

The association between cholecystectomy and gastroesophageal reflux symptoms: a prospective controlled study

artículo científico publicado en 2010

The cost of managing chronic hepatitis B infection: a global perspective

scientific article published on 01 November 2004

The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia

artículo científico publicado en 2004

The effect of periodic monitoring and feedback on screening colonoscopy withdrawal times, polyp detection rates, and patient satisfaction scores

artículo científico publicado en 2010

The hepcidin circuits act: balancing iron and inflammation

artículo científico publicado en 2011

The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.

artículo científico publicado en 2007

The importance of screening for hemochromatosis

artículo científico publicado en 2003

The predictors of the presence of varices in patients with primary sclerosing cholangitis

artículo científico publicado en 2010

The role of iron in nonalcoholic fatty liver disease: the story continues

scientific article published on 28 January 2010

The role of iron in the pathophysiology and treatment of chronic hepatitis C.

artículo científico publicado en 2009

Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission

artículo científico publicado en 2017

Tissue typing for HFE mutations

artículo científico publicado en 2002

To band or to block for primary prophylaxis against variceal bleeding?

scientific article published on 01 January 2006

Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.

artículo científico publicado en 2008

Treating NAFLD: future prospects

artículo científico publicado en 2006

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

artículo científico publicado en 2014

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

artículo científico publicado en 2015

Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.

artículo científico publicado en 2011

Update on hepatitis C treatment: systematic review of clinical trials

artículo científico publicado en 2016

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

artículo científico publicado en 2004

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

artículo científico publicado en 2019

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2018

Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?

artículo científico publicado en 2016

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation

artículo científico publicado en 2012

Vitamin K replacement in osteoporosis associated with cirrhosis: another reason to "eat your vegetables"?

scientific article published on 01 April 2002

Where do we go from HEIRS?

artículo científico publicado en 2006

You are what you wheat: effects of a whole-wheat diet compared with a refined-wheat diet on hepatic steatosis

scientific article published on 01 December 2018

[Endoscopic management of biliary complications after liver transplantation]

scientific article published on 01 July 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda